Hims & Hers Q4 2021 Earnings Report
Key Takeaways
Hims & Hers Health, Inc. reported a strong Q4 2021 with revenue reaching $84.7 million, a 104% increase year-over-year, and ending member subscriptions growing 95% year-over-year to 609,000. The company exceeded its revenue and Adjusted EBITDA guidance for both Q4 2021 and the full year 2021.
Q4 2021 revenue increased 104% year-over-year to $84.7 million.
Q4 2021 ending member subscriptions grew 95% year-over-year to 609,000.
Launched Hims & Hers mobile platform on the iOS app store.
Announced additional strategic national omnichannel retail collaborations with Amazon, CVS, GNC, Walgreens, and Walmart.
Hims & Hers
Hims & Hers
Hims & Hers Revenue by Segment
Forward Guidance
For Q1 2022, Hims & Hers expects revenue in the range of $90 million to $93 million and Adjusted EBITDA in the range of $(12) million to $(10) million. For full year 2022, the company expects revenue in the range of $365 million to $380 million and Adjusted EBITDA in the range of $(30) million to $(20) million.
Positive Outlook
- Revenue to be in the range of $90 million to $93 million for Q1 2022.
- Adjusted EBITDA to be in the range of $(12) million to $(10) million for Q1 2022.
- Revenue to be in the range of $365 million to $380 million for full year 2022.
- Adjusted EBITDA to be in the range of $(30) million to $(20) million for full year 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income